Direct injection trial aims to shrink tough sarcoma tumors
NCT ID NCT05755113
Summary
This study is testing whether injecting an experimental drug called tigilanol tiglate directly into tumors can destroy them in people with advanced soft tissue sarcoma. The trial will enroll about 40 adults to see if the injections shrink or eliminate the treated tumors and help control the cancer's spread. Researchers will also closely monitor safety and how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Memorial Sloan Kettering Cancer Centre
RECRUITINGNew York, New York, 10065, United States
Contact
Conditions
Explore the condition pages connected to this study.